Raymond James & Associates’s Alerian MLP ETF AMLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,180
Closed -$1K 3469
2017
Q4
$1K Hold
2,180
﹤0.01% 3409
2017
Q3
$1K Hold
2,180
﹤0.01% 3390
2017
Q2
$1K Buy
+2,180
New +$133K ﹤0.01% 3331
2016
Q3
Sell
-5,320
Closed -$47K 3219
2016
Q2
$47K Buy
5,320
+1,160
+28% +$69.9K ﹤0.01% 2875
2016
Q1
$23K Buy
+4,160
New +$211K ﹤0.01% 2842

Other funds holding AMLP

Raymond James & Associates's AMLP Position: Q3 2024 in Review

Raymond James & Associates increased its Alerian MLP ETF (AMLP) stake by 2.4% in Q3 2024, buying an estimated $1.17M and bringing the position to 1,061,519 shares worth $50M. The position accounts for 0.03% of the portfolio, ranked #440.

Raymond James & Associates first reported a position in AMLP in Q2 2013 and has held it in 46 quarters since. The position peaked at $68.2M in Q1 2024. 653 funds tracked by Wall St. Rank hold AMLP as of Q3 2024.

  • Raymond James & Associates held 1,061,519 shares of Alerian MLP ETF worth $50M as of Q3 2024.
  • Raymond James & Associates bought 24,674 Alerian MLP ETF shares in Q3 2024, an estimated $1.17M.
  • Alerian MLP ETF made up 0.03% of Raymond James & Associates's portfolio in Q3 2024, its #440 holding.
  • Raymond James & Associates first reported a position in Alerian MLP ETF in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Alerian MLP ETF position peaked at $68.2M in Q1 2024.
  • 653 funds tracked by Wall St. Rank held Alerian MLP ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.